机构：[1]State Key Laboratory of Proteomics, Collaborative Innovation Center for Cardiovascular Disorders, Genetic Laboratory of Development and Disease, Institute of Biotechnology[2]Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Molecular Cardiovascular Sciences[3]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University临床科室心脏内科中心首都医科大学附属安贞医院
第一作者机构：[1]State Key Laboratory of Proteomics, Collaborative Innovation Center for Cardiovascular Disorders, Genetic Laboratory of Development and Disease, Institute of Biotechnology
推荐引用方式(GB/T 7714)：
Lantao Liu ,Yao Song ,Linling Li ,et al.The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2018,72(16):C36-C36.doi:10.1016/j.jacc.2018.08.134.
APA：
Lantao Liu,,Yao Song,,Linling Li,,Song Zuo,,Nian Liu,...&Jian Wang.(2018).The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,72,(16)
MLA：
Lantao Liu,,et al."The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72..16(2018):C36-C36
医学